Published in Infect Immun on April 01, 1977
Fluorescent antibody study of the gram-positive anaerobic cocci. Appl Microbiol (1974) 1.78
Quantitative immunoelectrophoretic methods: a literature survey. Clin Chem (1975) 1.46
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
Virus myocardiopathy. Prog Med Virol (1973) 2.73
Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol (1969) 2.47
Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis (1983) 1.80
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77
Characteristics of pneumonias caused by Escherichia coli. N Engl J Med (1967) 1.68
Incubation of swab materials with herpes simplex virus. J Infect Dis (1980) 1.58
Coxsackievirus myocarditis--with special reference to acute and chronic effects. Prog Cardiovasc Dis (1985) 1.57
Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J Exp Med (1970) 1.54
Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis. JAMA (1978) 1.48
The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am (1978) 1.46
Editorial response: microbial persistence and idiopathic dilated cardiomyopathy. Clin Infect Dis (1999) 1.45
Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer. J Clin Oncol (1996) 1.32
Differential mechanisms of cytochrome P450 inhibition and activation by alpha-naphthoflavone. J Biol Chem (1997) 1.30
Characteristics of nonbacteremic Pseudomonas pneumonia. Ann Intern Med (1968) 1.27
Bacteroides pneumonias. Characteristics of cases with empyema. Ann Intern Med (1968) 1.26
Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. J Infect Dis (1976) 1.21
Herpesvirus hominis encephalitis in Michigan. Report of thirteen cases, including six treated with idoxuridine. N Engl J Med (1970) 1.18
Collecting duct carcinoma of the kidney. Br J Urol (1993) 1.18
Pneumonias caused by gram negative bacilli. Medicine (Baltimore) (1966) 1.18
Coxsackievirus myocardiopathy. J Infect Dis (1969) 1.17
Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1. Proc Soc Exp Biol Med (1972) 1.16
Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) (1978) 1.16
Xeroradiographic, bacteriologic, and pathologic studies in experimental staphylococcus osteomyelitis. Proc Soc Exp Biol Med (1977) 1.16
Localized mucormycosis following intramuscular corticosteroid. Case report and review of the literature. Am J Med Sci (1978) 1.16
Hemophilus influenzae bronchopneumonia in adults. Arch Intern Med (1968) 1.14
Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. Lancet (1983) 1.14
Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas. J Clin Oncol (1996) 1.13
Idoxuridine in herpes simplex virus (type 1) encephalitis. Experience with 29 cases in Michigan, 1966 to 1971. Ann Intern Med (1973) 1.12
An experimental approach to virus myocarditis. Prog Med Virol (1965) 1.09
A new continuing fatigue syndrome following mild viral illness. A proscription to exercise. Chest (1988) 1.08
Microbiologic assays and neurological toxicity during use of adenine arabinoside in humans. J Infect Dis (1976) 1.07
Theophylline-induced seizures: clinical and pathophysiologic aspects. West J Med (1983) 1.05
Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans. Infect Immun (1979) 1.05
Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis. Antimicrob Agents Chemother (1981) 1.04
Mycotic aneurysm and endocarditis. Two uncommon complications of salmonella infection in the same patient. Am J Cardiol (1966) 1.04
The classic bacterial pneumonias. Dis Mon (1975) 1.03
Complement-requiring neutralizing antibodies in Herpesvirus hominis encephalitis. J Immunol (1970) 1.02
Enterovirus hemagglutination: inhibition by several enzymes and sugars. J Immunol (1965) 1.02
A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J Infect Dis (1981) 1.01
Clinical manifestations of vasculitis in patients with solid tumors. A case report and review of the literature. Arch Intern Med (1994) 1.01
Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1. J Infect Dis (1974) 1.00
Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol (1970) 1.00
Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies. J Infect Dis (1974) 0.99
Virus myopericarditis. Ann Intern Med (1968) 0.99
CO binding kinetics of human cytochrome P450 3A4. Specific interaction of substrates with kinetically distinguishable conformers. J Biol Chem (1995) 0.98
Pseudomonas cepacia peritonitis associated with contamination of automatic peritoneal dialysis machines. Ann Intern Med (1982) 0.98
Non-traumatic gram-negative bacillary meningitis in the Detroit Medical Center, 1964-1974; (with special mention of cases due to Escherichia coli). Medicine (Baltimore) (1978) 0.97
Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J Infect Dis (1979) 0.97
Gentamicin in treatment of primary Gram-negative pneumonias. Am J Med Sci (1970) 0.96
Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J Infect Dis (1980) 0.96
Cellular interactions of several enteroviruses and a reovirus after treatment with sodium borohydride or carbohydrases. Virology (1968) 0.96
Preliminary results for positron emission mammography: real-time functional breast imaging in a conventional mammography gantry. Eur J Nucl Med (1996) 0.96
Some previously unrecognized features of herpes simplex virus encephalitis. Neurology (1978) 0.94
Characteristics and sequelae of paregoric abuse. Ann Intern Med (1966) 0.93
Enterovirus hemagglutination: inhibition by aldoses and a possible mechanism. J Immunol (1966) 0.92
Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. J Clin Invest (1978) 0.92
Agranulocytosis associated with chronic oral administration of cloxacillin for suppression of staphylococcal osteomyelitis. Am J Hematol (1982) 0.90
Granulocytopenia associated with carbenicillin. Five episodes in two patients. Am J Med (1973) 0.90
Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis. J Infect Dis (1984) 0.90
Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil (1996) 0.89
Gram-negative pneumonia in hospitalized patients. Postgrad Med (1975) 0.89
Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. Cancer Res (1995) 0.89
Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera. J Lab Clin Med (1974) 0.89
Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol (2007) 0.89
Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus. J Infect Dis (1975) 0.89
Congenital infections with reovirus. J Exp Med (1966) 0.89
Drug-drug interactions: effect of quinidine on nifedipine binding to human cytochrome P450 3A4. Biochem Pharmacol (1997) 0.89
The gram-negative bacillary pneumonias. Dis Mon (1980) 0.88
Pyrogenic reactions after inadvertent infusion of endotoxin during cardiac catheterizations. Ann Intern Med (1980) 0.87
Eczema herpeticum: presenting as hand, foot and mouth syndrome. Mich Med (1972) 0.87
Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals. J Infect Dis (1978) 0.86
Gram-negative bacillary pneumonia. J Infect Dis (1971) 0.86
Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa. J Infect (1984) 0.86
Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study. Biochemistry (2000) 0.86
Guide to immunization against mumps. J Infect Dis (1970) 0.86
Effect of periodate oxidation on hemagglutinating and antibody-producing capacities of certain enteroviruses and reoviruses. Proc Natl Acad Sci U S A (1966) 0.86
A mouse model of transmural myocardial necrosis due to coxsackievirus B4: observations over 12 months. Intervirology (1982) 0.86
Gentamicin/amikacin-resistant gram-negative bacilli at Detroit General Hospital, 1975-1976. Am J Med (1977) 0.85
Ventricular aneurysms complicating coxsackievirus group B, types 1 and 4 murine myocarditis. Circulation (1979) 0.85
Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. J Intern Med (1993) 0.84
Epidemiologic studies on influenza in familial and general population groups, 1951-1956. V. Effectiveness of adjuvant vaccines. Am J Epidemiol (1969) 0.84
Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia. Am J Med Sci (1984) 0.84
Interferon in biopsy and autopsy specimens of brain. Its presence in herpes simplex virus encephalitis. Arch Neurol (1980) 0.83
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy. Ann Oncol (2007) 0.83
Diminution in the size of the thymus in mice during forced swimming. J Infect Dis (1981) 0.83
Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis. Proc Soc Exp Biol Med (1976) 0.83
Herpetic whitlow: a manifestation of primary infection with herpes simplex virus type 1 or type 2. J Infect Dis (1978) 0.83
Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin. J Surg Oncol (1984) 0.83
Ultrasound imaging of residual limbs: new use for an old technique. Arch Phys Med Rehabil (1989) 0.82
Concentrations of idoxuridine in serum, urine, and cerebrospinal fluid of patients with suspected diagnoses of Herpesvirus hominis encephalitis. J Clin Invest (1972) 0.82
Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1. J Lab Clin Med (1977) 0.82
Assessment of cytosine arabinoside as an antiviral agent in humans. Antimicrob Agents Chemother (1974) 0.82
Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits. Antimicrob Agents Chemother (1980) 0.82
An estimate of the course of herpes simplex virus encephalitis. Scand J Infect Dis (1976) 0.81
Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J Clin Oncol (1996) 0.81
Organizational manipulation of gonadal hormones and systemic morphine analgesia in female rats: effects of adult ovariectomy and estradiol replacement. Brain Res (2005) 0.81
Epidemiologic aspects of postoperative sepsis in a urologic practice (with a note concerning antibacterial prophylaxis). J Urol (1971) 0.81
A small, randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome. Clin Infect Dis (2001) 0.81
Characteristics of bacterial endocarditis in heroin addicts in Detroit. Am J Med Sci (1976) 0.80